| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 26, 2010
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has acquired rights to Novel Laboratories' pending ANDA for HalfLytely® and Bisacodyl Tablets Bowel Prep Kit (PEG-3350, sodium...
-
May 24, 2010
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that Perrigo Chairman and CEO Joseph C. Papa will present at the Citi Investment Research Global Health Care Conference on Wednesday, May...
-
May 5, 2010
Perrigo (NASDAQ: PRGO)( TASE: PRGO) today announced that it has acquired the exclusive U.S. store brand rights to sell and distribute Dextromehtorphan Polistirex Extended Release Suspension Cough...
-
May 3, 2010
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has closed the previously announced acquisition of PBM Holdings, Inc., the world's largest manufacturer of infant formula for...
-
Apr 29, 2010
-- Fiscal third quarter revenue from continuing operations increased $32 million, or 6%, to $538 million -- Fiscal third quarter adjusted income from continuing operations increased 49% to $70...